POINT BIOPHARMA GLOBAL INC. Net Income
POINT BIOPHARMA GLOBAL INC. reported Net Income of -$24.77 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2023-11-13
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for the quarter ending 2023-09-30 was -$24.77M.
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for the quarter ending 2023-06-30 was -$25.41M.
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for the quarter ending 2023-03-31 was -$16.53M.
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for the quarter ending 2022-12-31 was $163.27M.
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for fiscal 2022 was $98.29M.
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for fiscal 2021 was -$45.90M.
- POINT BIOPHARMA GLOBAL INC. net income (loss) attributable to parent for fiscal 2020 was -$13.37M.
| Period end | Net Income (Loss) Attributable to Parent 2 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | -$24.77M 10-Q · filed 2023-11-13 | -$50.19M derived: sum of 2 quarters · filed 2023-11-13 | -$66.72M 10-Q · filed 2023-11-13 | $96.55M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-06-30 | -$25.41M 10-Q · filed 2023-11-13 | -$41.94M 10-Q · filed 2023-08-14 | $121.33M derived: sum of 3 quarters · filed 2023-11-13 | $97.31M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2023-03-31 | -$16.53M 10-Q · filed 2023-11-13 | $146.74M derived: sum of 2 quarters · filed 2023-11-13 | $122.72M derived: sum of 3 quarters · filed 2023-11-13 | $98.14M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-12-31 | $163.27M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $139.25M derived: sum of 2 quarters · filed 2023-11-13 | $114.67M derived: sum of 3 quarters · filed 2023-11-13 | $98.29M 10-K · filed 2023-03-27 | ||
| 2022-09-30 | -$24.01M 10-Q · filed 2023-11-13 | -$48.59M derived: sum of 2 quarters · filed 2023-11-13 | -$64.97M 10-Q · filed 2023-11-13 | -$79.17M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$24.58M 10-Q · filed 2023-11-13 | -$40.96M 10-Q · filed 2023-08-14 | -$55.16M derived: sum of 3 quarters · filed 2023-11-13 | -$72.27M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-03-31 | -$16.38M 10-Q · filed 2023-11-13 | -$30.58M derived: sum of 2 quarters · filed 2023-11-13 | -$47.69M derived: sum of 3 quarters · filed 2023-11-13 | -$56.50M derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2021-12-31 | -$14.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | -$31.31M derived: sum of 2 quarters · filed 2023-03-27 | -$40.12M derived: sum of 3 quarters · filed 2023-03-27 | -$45.90M 10-K · filed 2023-03-27 | ||
| 2021-09-30 | -$17.12M 10-Q · filed 2022-11-14 | -$25.92M derived: sum of 2 quarters · filed 2022-11-14 | -$31.71M 10-Q · filed 2022-11-14 | -$31.83M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | -$8.80M 10-Q · filed 2022-11-14 | -$14.59M 10-Q · filed 2022-08-12 | -$14.72M derived: sum of 3 quarters · filed 2022-11-14 | -$17.76M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-03-31 | -$5.78M 10-Q · filed 2022-11-14 | -$1.40M 10-Q · filed 2021-04-29 | -$5.91M derived: sum of 2 quarters · filed 2022-11-14 | -$8.96M derived: sum of 3 quarters · filed 2022-11-14 | -$12.15M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2020-12-31 | -$126.81K derived: 10-K 9 month − 10-Q 6 month · filed 2021-03-04 | -$3.17M derived: sum of 2 quarters · filed 2021-11-12 | -$311.51K 10-K · filed 2021-03-04 | -$13.37M 10-K · filed 2022-03-25 | ||
| 2020-09-30 | -$3.05M 10-Q · filed 2021-11-12 | -$165.34K 10-Q · filed 2020-11-02 | -$184.71K 10-Q · filed 2020-11-02 | -$7.82M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$19.37K 10-Q · filed 2020-11-02 | -$3.19M 10-Q · filed 2021-11-12 | -$4.77M 10-Q · filed 2021-08-13 | |||
| 2020-03-31 | -$1.58M 10-Q · filed 2021-11-12 |